An evaluation of sulfasymazine in infections in mice.
D000818:Animals; D004927:Escherichia coli Infections / Q000188:drug therapy*; D007239:Infections / Q000188:drug therapy*; D007709:Klebsiella; D051379:Mice; D010326:Pasteurella Infections / Q000188:drug therapy*; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013411:Sulfadiazine / Q000097:blood / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use*; D013444:Sulfisoxazole / Q000097:blood / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D014227:Triazines / Q000627:therapeutic use*
D013424:Sulfanilamides; D013449:Sulfonamides; D014227:Triazines; D013411:Sulfadiazine; D013444:Sulfisoxazole